Please Wait.....
Report
Cell-Based Assays: Technologies and Global Markets
Market Research Report I 2025-02-11 I 139 Pages I BCC Research
Description
Report Scope
The scope of this report on the global market for cell-based assay technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, application and end user. The report breaks down the cell-based assay market into four product categories: instruments, consumables, services, and software. It also segments the market by application, such as drug discovery; absorption, distribution, metabolism, and excretion (ADME)/toxicity testing; and basic research. The end users considered in the report include academic and research institutions, pharmaceutical and biotech companies, and clinical research organizations.
Geographically, the analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report also provides profiles of key market players and highlights industry trends, major products, mergers and acquisitions, and other partnerships expected to influence the future of the industry.
Report Includes
- 23 data tables and 48 additional tables
- Analyses of the trends in the global market for cell-based assays, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the market's current and future potential
- Estimates of the market for cell-based assays, revenue forecasts, and corresponding market share analysis by product, type/application, end user and geographic region
- Assessment of the current market, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
- Coverage of major issues involved in the R&D of more effective cell-based approaches for drug discovery
- Information on increasing investments in R&D activities, key technology issues, industry-specific challenges, major types of end users, and COVID-19 implications
- Discussion of ESG challenges and practices of the industry
- Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
- Information on recent mergers and acquisitions, expansions, collaborations, investments, divestments and product launches
- Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA., Danaher Corp., Bio-Rad Laboratories Inc., and Charles River Laboratories.
Executive Summary
Summary:
The global cell-based assay market was $32.4 billion in 2023 and is expected to grow at a CAGR of 9.8% to reach $56.3 billion by the end of 2029. The market's growth is propelled by multiple factors that contribute to its expansion across many sectors, particularly in drug discovery, toxicity testing, and basic research. Cell-based assays, which utilize live cells to evaluate biological activity, are revolutionizing the life sciences industry by offering more accurate and physiologically relevant models compared to traditional methods such as animal testing. As these assays continue to evolve, they are helping to accelerate drug development processes, improving the efficacy and safety profiles of therapeutic candidates while also reducing animal testing and increasing cost efficiency.
A driver of the cell-based assay market is the increasing demand for novel drug discovery techniques. Pharmaceutical and biotech companies are investing in cell-based assays for high-throughput screening (HTS) to identify potential drug candidates, to evaluate drug efficacy, and to assess compound toxicity early in the drug development process. Compared to traditional biochemical assays, cell-based assays provide more predictive, human-relevant data, which is fundamental for the successful development of new therapeutics. As the pharmaceutical industry seeks to reduce the cost and time of bringing drugs to market, cell-based assays are being adopted as a more efficient alternative.
Additionally, the rise in chronic diseases such as cancer, cardiovascular disease (CVD), diabetes, and neurological disorders is driving the need for more effective and targeted therapies. As these diseases continue to affect a large portion of the global population, the demand for cell-based assays in both basic and clinical research has grown. Researchers are using these assays to better understand disease mechanisms at the cellular level, to identify potential biomarkers, and to evaluate drug responses more accurately. This has led to a surge in R&D investment to advance new cell-based assay technologies.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Drug Discovery
Importance of Cell-based Assays
Cell Signaling Pathways
Mechanisms of Drug Action
Gene Expression Regulation
Cytotoxicity and Viability
Disease Modeling
Types of Cell-based Assays
Cell Viability Assays
Cell Proliferation Assays
Cytotoxicity Assays
Application of Cell-based Assays
Drug Discovery and Development
Toxicology Studies
Cancer Research
Infectious Disease Research
Immunology and Inflammation
Molecular Pathway Analysis
Regenerative Medicine and Tissue Engineering
Biomarker Discovery and Validation
Precision and Personalized Medicine
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Rising Demand for Drug Discovery and Development
High Demand for Personalized Medicine
Increasing Investment in Drug R&D
Market Restraints
High Cost of Assay Development and Maintenance
Technical Challenges and Complexity
Short Shelf-life of Reagents and Consumables
Market Opportunities
Expanding Applications in Drug Discovery
Expansion in Diagnostics and Biomarker Discovery
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
CRISPR/Cas9 Technology
High-content Screening (HCS) and Imaging
AI and Machine Learning (ML) in Data Analysis
Patent Analysis
Patent Review, by Leading Jurisdiction
Chapter 5 Market Segmentation Analysis
Overview
Segmentation Breakdown
Cell-based Assays: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Software
Services
Market Analysis by Application
Drug Discovery
Absorption, Distribution, Metabolism, and Excretion (ADME)/Toxicity
Basic Research
Market Analysis by End User
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Competitive Landscape
Ranking of Companies in the Cell-based Assay Market
Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective
Sustainability in the Cell-based Assay Market
Animal Testing
Miniaturization and Automation
Green Chemistry and Eco-friendly Materials
3D Cell Cultures and Tissue Models
Waste Reduction and Optimization of Resources
Improving Drug Discovery Efficiency
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIOIVT
BIO-RAD LABORATORIES INC.
CELL BIOLABS INC.
CELL BIOLOGICS INC.
CHARLES RIVER LABORATORIES
DANAHER CORP.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
LONZA
MERCK KGAA
PROMEGA CORP.
REVVITY
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for Cell-based Assays, by Product Type, Through 2029
Summary Table B : Global Market for Cell-based Assays, by Region, Through 2029
Table 1 : Factors in Cell-based Assay Development
Table 2 : Types of Cellular Assays
Table 3 : New Cases and Deaths Due to Selected Cancers Globally, 2022
Table 4 : U.S. NIH Funding for Selected Diseases, 2019-2023
Table 5 : Existing Cell-based Assay Technologies
Table 6 : Patents Issued for Cell-based Assays, by Jurisdiction, 2022-2024
Table 7 : Global Market for Cell-based Assays, Through 2029
Table 8 : Global Market for Cell-based Assays, by Product Type, Through 2029
Table 9 : Global Market for Cell-based Assays, by Application, Through 2029
Table 10 : Global Market for Cell-based Assays, by End User, Through 2029
Table 11 : Global Market for Cell-based Assays, by Region, Through 2029
Table 12 : North American Market for Cell-based Assays, by Country, Through 2029
Table 13 : European Market for Cell-based Assays, by Country, Through 2029
Table 14 : Asia-Pacific Market for Cell-based Assays, by Country, Through 2029
Table 15 : RoW Market for Cell-based Assays, by Subregion, Through 2029
Table 16 : Ranking of Companies in Cell-based Assay Market, 2023
Table 17 : ESG Rankings for Major Cell-based Assay Companies, 2024*
Table 18 : Information Sources in This Report
Table 19 : Abbreviations Used in this Report
Table 20 : Agilent Technologies Inc.: Company Snapshot
Table 21 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 22 : Agilent Technologies Inc.: Product Portfolio
Table 23 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 24 : BD: Company Snapshot
Table 25 : BD: Financial Performance, FY 2023 and 2024
Table 26 : BD: Product Portfolio
Table 27 : BD: News/Key Developments, 2024
Table 28 : BioIVT: Company Snapshot
Table 29 : BioIVT: Product Portfolio
Table 30 : BioIVT: News/Key Developments, 2023 and 2024
Table 31 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 32 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 33 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 34 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 35 : Cell Biolabs Inc.: Company Snapshot
Table 36 : Cell Biolabs Inc.: Product Portfolio
Table 37 : Cell Biologics Inc.: Company Snapshot
Table 38 : Cell Biologics Inc.: Product Portfolio
Table 39 : Charles River Laboratories: Company Snapshot
Table 40 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 41 : Charles River Laboratories: Product Portfolio
Table 42 : Charles River Laboratories: News/Key Developments, 2023 and 2024
Table 43 : Danaher Corp.: Company Snapshot
Table 44 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 45 : Danaher Corp.: Product Portfolio
Table 46 : Fujifilm Holdings Corp.: Company Snapshot
Table 47 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Fujifilm Holdings Corp.: Product Portfolio
Table 49 : GE Healthcare: Company Snapshot
Table 50 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 51 : GE Healthcare: Product Portfolio
Table 52 : Lonza: Company Snapshot
Table 53 : Lonza: Financial Performance, FY 2022 and 2023
Table 54 : Lonza: Product Portfolio
Table 55 : Lonza: News/Key Developments, 2021
Table 56 : Merck KGaA: Company Snapshot
Table 57 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 58 : Merck KGaA: Product Portfolio
Table 59 : Promega Corp.: Company Snapshot
Table 60 : Promega Corp.: Product Portfolio
Table 61 : Promega Corp.: News/Key Developments, 2023
Table 62 : Revvity: Company Snapshot
Table 63 : Revvity: Financial Performance, FY 2022 and 2023
Table 64 : Revvity: Product Portfolio
Table 65 : Revvity: News/Key Developments, 2023 and 2024
Table 66 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 67 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 69 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure A : Global Market for Cell-based Assays, by Product Type, 2021-2029
Summary Figure B : Global Market for Cell-based Assays, by Region, 2021-2029
Figure 1 : Projected Global Aging Population (65 Years and Above), 1990-2050
Figure 2 : Drug Discovery Process Steps
Figure 3 : Market Dynamics of Cell-based Assays
Figure 4 : FDA Approval of Personalized Medicines, 2015-2022
Figure 5 : Pharmaceutical R&D Spending, by Country/Region, 2010-2022
Figure 6 : Shares of Global Market for Cell-based Assays, by Product Type, 2023
Figure 7 : Shares of Global Market for Cell-based Assays, by Application, 2023
Figure 8 : Shares of Global Market for Cell-based Assays, by End User, 2023
Figure 9 : R&D Spending of Biopharmaceutical Companies, 2010-2024
Figure 10 : Shares of Global Market for Cell-based Assays, by Region, 2023
Figure 11 : Shares of North American Market for Cell-based Assays, by Country, 2023
Figure 12 : Shares of European Market for Cell-based Assays, by Country, 2023
Figure 13 : Shares of Asia-Pacific Market for Cell-based Assays, by Country, 2023
Figure 14 : Shares of RoW Market for Cell-based Assays, by Subregion, 2023
Figure 15 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 16 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2024
Figure 18 : BD: Revenue Share, by Country/Region, FY 2024
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 22 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 26 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 27 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 28 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 29 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security